Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Cardiovascular medicine stands at a pivotal crossroads—shaped by rapid advances in precision therapies, a deepening understanding of disease mechanisms, and an urgent imperative to address global health disparities. As the burden of cardiovascular disease continues to evolve, so too does the need for nuanced, evidence-based approaches that span the full spectrum of care: from prevention […]

EUROPEAN JOURNAL OF ARRHYTHMIA & ELECTROPHYSIOLOGY – VOLUME 6 SUPPLEMENT 1 – 2020

Select a Section…
1

Young Investigators Competition – Basic Science

2 mins
ML Beach (Presenting Author) - King’s College London, London; A Mehta - King’s College London, London; I Sim - King’s College London, London; C Corrado - King’s College London, London; R Bendikas - King’s College London, London; JA Solis-Lemus - King’s College London, London; O Razeghi - King’s College London, London; J Whitaker - King’s College London, London; L O’Neill - King’s College London, London; G Plank - University of Graz, Graz; EJ Vigmond - LIRYC University of Bordeaux, Bordeaux; SE Williams - King’s College London, London; MD O’Neill - King’s College London, London; CH Roney - King’s College London, London; SA Niederer - King’s College London, London

Introduction: There are numerous approaches to treating Atrial Fibrillation (AF) using catheter ablation therapy. These approaches still require optimisation, with 41% of persistent AF patients reverting to AF 18 months after receiving pulmonary vein isolation (PVI). We aimed to use a virtual cohort of patient-specific left atrial models to compare ablation techniques targeting the anatomical, […]

2 mins
VS Rathod (Presenting Author) - Queen Mary University, London; SC Harmer - Queen Mary University, London; A Royale - Queen Mary University, London; Q Aziz - Queen Mary University, London; PD Lambiase - Queen Mary University, London; A Tinker - Queen Mary University, London

Phosphatidylinositol-4,5-biphosphate (PIP2) is implicated in the regulation and modulation of the IKS channel. The channel is formed at the plasma membrane by the co-assembly of KCNQ1 and KCNE1. Patients with Congenital Long QT 1(LQT1) syndrome are predisposed to Polymorphic VT due to mutations in KCNQ1, leading to impaired channel activity. We initially transfect Human Embryonic Kidney (HEK) […]

< 1 min
A Saljic* - Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; L Soattin* (Presenting Author) - Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; DS Trachsel - Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; K Boddum - Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; T Jespersen - Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (*joint first authors)

Introduction: Antisense locked nucleic acids (LNA) GapmeRs are stable small oligonucleotides able to bind their mRNA target with high affinity and induce gene silencing. Small conductance calcium-activated potassium (SK) channels represent a novel target for rhythm control therapy in atrial fibrillation (AF). We designed specific SK3-LNA-GapmeRs, which in vitro demonstrated specific SK3-knockdown. Here, we show the effect […]

2

Young Investigators Competition – Clinical Science

2 mins
V Kanthasamy (Presenting Author) - Barts and London NHS Trust, London; J Cranfield - Barts and London NHS Trust, London; A Creta - Barts and London NHS Trust, London; R Hunter - Barts and London NHS Trust, London; R Schilling - Barts and London NHS Trust, London; M Earley - Barts and London NHS Trust, London; V Ezzat - Barts and London NHS Trust, London; S Sporton - Barts and London NHS Trust, London; M Lowe - Barts and London NHS Trust, London; M Finlay - Barts and London NHS Trust, London

Introduction: Recently published data from a US nationwide database reported a strikingly high mortality rate of 0.46% within 30 days of a catheter ablation (CA) following atrial fibrillation (AF) procedure. We hypothesized that early mortality from AF ablation may generally be significantly higher than previously reported, and reported low mortality rates of <0.1% may be artefactual […]

3 mins
MY Kim (Presenting Author) - Imperial College London, London; S Koutsoftidis - Imperial College London, London; RS Chowdhury - Imperial College London, London; DR Tomlinson - University Hospitals Plymouth NHS Trust, Plymouth; C Coyle - Imperial College London, London; MB Sikkel - Imperial College London, London; KM Leong - Imperial College London, London; V Luther - Imperial College Healthcare NHS Trust, London; L Malcolme-Lawes - Imperial College Healthcare NHS Trust, London; A Sohaib - Barts Healthcare NHS Trust, London; B Sandler - Imperial College London, London; J Nesbitt - Imperial College London, London; CD Cantwell - Imperial College London, London; R Ali - Imperial College London, London; RJ Hunter - Barts Health NHS Trust, London; M Koa-Wing - Imperial College Healthcare NHS Trust, London; NA Qureshi - Imperial College Healthcare NHS Trust, London; ZI Whinnett - Imperial College Healthcare NHS Trust, London; PB Lim - Imperial College Healthcare NHS Trust, London; NS Peters - Imperial College London, London; E Drakakis - Imperial College London, London; FS Ng - Imperial College London, London; NWF Linton - Imperial College London, London; P Kanagaratnam - Imperial College London, London

Background: The autonomic nervous system may be a driver for atrial fibrillation (AF). High frequency stimulation (HFS) can locate distinct ganglionated plexus (GP) that trigger PV or atrial ectopy/AF (ET-GP), and atrioventricular (AV) dissociation causing significant bradycardia (AVD-GP). We hypothesised that ablating these sites prevent AF. Methods and results: In patients with paroxysmal AF, a […]

2 mins
C Scrocco (Presenting Author) - St George’s University of London, St George’s Hospital NHS Trust, London; A Ghahramanyan - St George’s University of London, St George’s Hospital NHS Trust, London; B Ensam - St George’s University of London, St George’s Hospital NHS Trust, London; Y Ben-Haim - St George’s University of London, St George’s Hospital NHS Trust, London; B Gray - Royal Princes Alfred Hospital, Sydney; A Varnava - Imperial College Healthcare Trust, London; M Tome-Esteban - St George’s University of London, St George’s Hospital NHS Trust, London; M Papadakis - St George’s University of London, St George’s Hospital NHS Trust, London; S Sharma - St George’s University of London, St George’s Hospital NHS Trust, London; I Chis Ster - St George’s University of London, London; E R Behr - St George’s University of London, St George’s Hospital NHS Trust, London

Background: Data on quantitative assessment of dynamic ST changes during 12-lead 24-hour ambulatory ECG in Brugada Syndrome (BrS) are limited. Aim: To investigate whether the quantitative analysis of ST changes during 12-lead 24-hour ambulatory ECG could contribute to the diagnosis and risk stratification of BrS. Methods: A total of 147 BrS patients (55% male, mean […]

3

Oral Abstracts 1 – Allied & Service Development

2 mins
J Collinson (Presenting Author) - Essex CTC, Basildon and Thurrock University Hospital, Basildon; Z Begum - Essex CTC, Basildon and Thurrock University Hospital, Basildon; A Chavner - Essex CTC, Basildon and Thurrock University Hospital, Basildon; V Rathod - Essex CTC, Basildon and Thurrock University Hospital, Basildon; J Sibley - Essex CTC, Basildon and Thurrock University Hospital, Basildon; S Tan - Essex CTC, Basildon and Thurrock University Hospital, Basildon; D Farwell - Essex CTC, Basildon and Thurrock University Hospital, Basildon; S Harris - Essex CTC, Basildon and Thurrock University Hospital, Basildon

Background: The 2015 Heart Rhythm Society consensus statement on remote interrogation and monitoring of cardiovascular implantable electronic devices (CIEDs) recommends that all CIEDs be checked through direct patient contact 2-12 weeks post implant. The COVID19 pandemic forced our pacemaker (PPM) service to deviate from this recommendation. We enrolled patients to remote monitoring (RM) from implant […]

2 mins
KH Sanders (Presenting Author) - Cambridge University Hospitals, Cambridge; PJ Pugh - Cambridge University Hospitals, Cambridge

Background: There is a gap in evidence regarding optimal management of patients approaching elective device replacement. We do not know what proportion of patients may benefit from a change in device prescription, whether upgrade or downgrade, as a result of changes in clinical status. To date there are no randomised controlled trials regarding changes to […]

2 mins
S Jones (Presenting Author) - Barts Health NHS Trust, London; C Monkhouse - Barts Health NHS Trust, London

Introduction: Covid 19-drove healthcare services to adapt in order to keep patients and staff safe from the virus. As a Cardiac Scientist (CS) manager, I was charged with developing a strategy for the Cardiac Device Follow-up service across a tertiary cardiac centre with satellite sites. We routinely performed face-to-face follow-up for 100 patients per day […]

2 mins
J Shukla (Presenting Author) - Federated4Health, London; A Ahmed - Federated4Health, London; R Chowdhury - Federated4Health, London; A Lim - Federated4Health, London; A Sadiq - Federated4Health, London; C Osmund - Federated4Health, London; H Rawesh - Federated4Health, London; L Nwoye - Federated4Health, London; L Khatib - Federated4Health, London; M Battal - Federated4Health, London; S Naz - Federated4Health, London

Introduction: Clinical pharmacists are a new workforce in Primary Care Networks (PCN) and can play a critical role in realising the NHS Long Term Plan ambition, principally through secondary prevention.1 A centralised pharmacist model was implemented in the delivery of the NHSE Atrial Fibrillation (AF) patient optimisation demonstrator programme 2018-2020 aimed at preventing AF related stroke […]

3 mins
LH Bayliss (Presenting Author) - Barts Heart Centre, London; P Lloyd - Barts Heart Centre, London; Z Carter - Barts Heart Centre, London; CA Monkhouse - Barts Heart Centre, London; M Earley - Barts Heart Centre, London; A Muthumala - Barts Heart Centre, London; P Moore - Barts Heart Centre, London; S Jones - Barts Heart Centre, London

Background: On the 23rd March 2020 the UK went into lockdown due to COVID-19 with vulnerable patients advised to shield at home. Patients with implantable devices still required battery changes and other interventions during this period, both clinically urgent and routine. A new strategy for identifying those needing urgent procedures was introduced at a tertiary […]

3 mins
C De Olveira (Presenting Author) - Barts Heart Centre, London; R Mravljak - Barts Heart Centre, London; G Erandio - Barts Heart Centre, London; H Page - Barts Heart Centre, London; G Peacock - Barts Heart Centre, London; T Ganeswaran - Barts Heart Centre, London; I Rosario - Barts Heart Centre, London; A Muthumala - Barts Heart Centre, London; P Moore - Barts Heart Centre, London; S Jones - Barts Heart Centre, London; C Monkhouse - Barts Heart Centre, London

Introduction: Device follow up was routinely performed in person pre-March 2020. When the COVID pandemic caused lockdown in the UK this led to new methods of performing the 4-6-week check: utilising remote monitoring and patients sending wound images. We wanted to investigate the patient’s perspective of this experience: comparing traditional follow up vs remote only […]

4

Oral Abstracts 1 – AF: Clinical

2 mins
PS Burdett - Liverpool Centre for Cardiovascular Science, Liverpool Health Partners, Liverpool, United Kingdom; GYH Lip - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool

Background: Atrial fibrillation (AF) is a common arrhythmia and is associated with a high risk of mortality and morbidity due to stroke, heart failure and dementia. AF is a major contributor to healthcare costs, but we need greater understanding of the main cost drivers (e.g. hospitalisations) of this increasingly prevalent arrhythmia. Such data would help […]

2 mins
Y Kassir (Presenting Author) - East Sussex Healthcare NHS Trust, Eastbourne; R Dulai - East Sussex Healthcare NHS Trust, Eastbourne; C Uy - East Sussex Healthcare NHS Trust, Eastbourne; V Maravilla - East Sussex Healthcare NHS Trust, Eastbourne; NR Patel - East Sussex Healthcare NHS Trust, Eastbourne; N Sulke - East Sussex Healthcare NHS Trust, Eastbourne; RA Veasey - East Sussex Healthcare NHS Trust, Eastbourne; S Furniss - East Sussex Healthcare NHS Trust, Eastbourne

Introduction: Atrial fibrillation (AF) ablation is the most common arrhythmia procedure performed worldwide. The number of AF ablation procedures has increased exponentially over the past decade. This has a significant impact on healthcare resources and cost implications. The aim of this study is to evaluate the efficacy and safety of a same-day nurse led discharge […]

< 1 min
A Creta (Presenting Author) - Barts Heart Centre, London; N Ventrella - Campus Bio-Medico University, Rome; R Providencia - Barts Heart Centre, London; MJ Earley - Barts Heart Centre, London; S Sporton - Barts Heart Centre, London; AW Chow - Barts Heart Centre, London; PD Lambiase - Barts Heart Centre, London; M Lowe - Barts Heart Centre, London; RJ Schilling - Barts Heart Centre, London; M Finlay - Barts Heart Centre, London; RJ Hunter - Barts Heart Centre, London

Introduction: The frequency of catheter ablation for atrial fibrillation (AF) has increased dramatically, stretching resources. Discharge on the same day as treatment may increase the efficiency and throughput. There are limited data regarding the safety of this strategy. Methods: We performed a retrospective analysis of consecutive patients undergoing AF ablation in a tertiary centre and […]

2 mins
WYD Ding (Presenting Author) - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool; GYH Lip - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool; SB Bartoletti - Liverpool Heart & Chest Hospital, Liverpool; LM Morrison - Liverpool Heart & Chest Hospital, Liverpool; AK Khalatbari - Liverpool Heart & Chest Hospital, Liverpool; SA Aggarwal - Liverpool Heart & Chest Hospital, Liverpool; PV Velavan - Liverpool Heart & Chest Hospital, Liverpool; DG Gupta - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool

Background: Left atrial appendage (LAA) occlusion is offered for stroke prevention in patients with atrial fibrillation (AF) who are unsuitable for lifelong oral anticoagulation. Medium to long term follow up (FU) data for this high-risk cohort are sparse. Methods: We report 4-year FU outcomes in 73 patients (median age 78 [73-82] years; 34.2% female) who […]

2 mins
CP Uy (Presenting Author) - East Sussex Hospitals NHS Trust, Eastbourne; R Dulai - East Sussex Hospitals NHS Trust, Eastbourne; Y Kassir - East Sussex Hospitals NHS Trust, Eastbourne; V Maravilla - East Sussex Hospitals NHS Trust, Eastbourne; NR Patel - East Sussex Hospitals NHS Trust, Eastbourne; N Sulke - East Sussex Hospitals NHS Trust, Eastbourne; S Furniss - East Sussex Hospitals NHS Trust, Eastbourne; RA Veasey - East Sussex Hospitals NHS Trust, Eastbourne

Introduction: Second-generation cryoballoon ablation is safe and effective in patients with paroxysmal atrial fibrillation (AF). Previous studies have found there to be high acute rates of pulmonary vein (PV) isolation with the Artic Front Advance catheter. Reaching a nadir temperature of -40° has also been shown to achieve electrical isolation of the pulmonary veins. The […]

2 mins
B Li (Presenting Author) - The Essex Cardiothoracic Centre, Nethermayne, Basildon, Essex; L Zydzik - Jagiellonian University Medical College, Krakow; S Tan - The Essex Cardiothoracic Centre, Nethermayne, Basildon, Essex; P Cliffe - The Essex Cardiothoracic Centre, Nethermayne, Basildon, Essex; J Pintacasi - The Essex Cardiothoracic Centre, Nethermayne, Basildon, Essex; S Langley - The Essex Cardiothoracic Centre, Nethermayne, Basildon, Essex; A Hardy-Wallace - The Essex Cardiothoracic Centre, Nethermayne, Basildon, Essex; S Harris - The Essex Cardiothoracic Centre, Nethermayne, Basildon, Essex; P Phen - The Essex Cardiothoracic Centre, Nethermayne, Basildon, Essex; R M Barbagallo - The Essex Cardiothoracic Centre, Nethermayne, Basildon, Essex; J N Dungu - The Essex Cardiothoracic Centre, Nethermayne, Basildon, Essex; H O Savage - The Essex Cardiothoracic Centre, Nethermayne, Basildon, Essex

Introduction: Guidelines recommend providing primary care practitioners direct access to echocardiography (echo), prior to specialist cardiology input, in patients whom they suspect have heart failure, based on symptoms and raised N-Terminal pro Brain Natriuretic Peptide (NTproBNP). Early access can lead to increased detection of Heart Failure with a reduced Ejection Fraction (HFrEF). However, it is […]

5

Oral Abstracts 2 – High Scoring Abstracts

< 1 min
DG Gupta (Presenting Author) - Liverpool Heart and Chest Hospital, Liverpool; TH Hunter - Clinical Trial & Consulting, Covington; JV Vijgen - Virga Jessa Ziekenhuis, Hasselt; TD De Potter - Onze Lieve Vrouwziekenhuis Ziekenhuis Aalst-Asse-Ninove, Aalst; DS Scherr - Medical University Graz, Graz; HV Van Herendael - Ziekenhuis Oost – Limburg Campus, Genk; SK Knecht - AZ St Jan Brugge, Brugge; RK Kobza - Luzerner Kantonsspital Herzzentrum, Luzern; BB Berte - Luzerner Kantonsspital Herzzentrum, Luzern; NS Sandgaard - Odense University Hospital, Odense; JA Albenque - Clinique Pasteur, Toulouse; GS Szeplaki - Mater Private Hospital, Dublin; YJS Stevenhagen - Thoraxcentrum, Enschede; PT Taghji - Clinical Clairval Marseille, Marseille; MW Wright - St. Thomas Hospital London, London; MD Duytschaever - AZ St Jan Brugge, Brugge

Background: Prior studies have shown that a standardized pulmonary vein isolation (PVI) workflow guided by a single ablation index (AI) value and a maximum interlesion distance (ILD) between corresponding ablation tags is associated with high single-procedure 1-year clinical success. Improvement in 1-year success may translate to lower cardiovascular healthcare utilization. Purpose: To evaluate the effect […]

2 mins
NT Srinivasan (Presenting Author) - Barts Heart Centre, St Bartholomew’s Hospital, London; N Papageorgio - Barts Heart Centre, London; J Garcia - Barts Heart Centre, London; G Babu - Bournemouth Hospital, Bournemouth; S Ahsan - Barts Heart Centre, London; RJ Hunter - Barts Heart Centre, London; RJ Schilling - Barts Heart Centre, London; AW Chow - Barts Heart Centre, London; PD Lambiase - Barts Heart Centre, London

Background: The presence of dynamic substrate changes facilitates functional block and re-entry in ventricular tachycardia (VT) but are rarely studied as part of clinical VT mapping. We aimed to compare outcomes of ablation to dynamic functional substrate against standard institutional protocol. Methods: Thirty patients (age 67 ± 9 yrs, 27 male) with ischemic cardiomyopathy undergoing […]

2 mins
J Julia Calvo (Presenting Author) - Brighton and Sussex University Hospitals NHS Trust, Brighton; S Kirubakaran - Queen Alexandra Hospital, Portsmouth; S Podd - Royal Devon and Exeter Hospital, Exeter; G Babu - Royal Bournemouth Hospital, Bournemouth; R Balasubramaniam - Royal Bournemouth Hospital, Bournemouth; PB Lim - Hammersmith Hospital, London; M Wright - Guy’s and St Thomas’ Hospital, London; R Veasey - Eastbourne DGH, Eastbourne; I Mann - Brighton and Sussex University Hospitals NHS Trust, Brighton; J McCready - Brighton and Sussex University Hospitals NHS Trust, Brighton; J Silberbauer - Brighton and Sussex University Hospitals NHS Trust, Brighton

Introduction: Access to the epicardial substrate is often required during scar-related ventricular tachycardia (VT) ablation, either as first approach or following a previous endocardial failure. Epicardial ablation is however far from being a widespread technique among electrophysiology labs, due to the intrinsic complications associated with this technique. In 2017, we described our initial results using […]

2 mins
MS Alam (Presenting Author) - Nottingham University Hospitals NHS Trust, Nottingham; AJ Ahsan - Nottingham University Hospitals NHS Trust, Nottingham; S Jamil-Copley - Nottingham University Hospitals NHS Trust, Nottingham; AD Staniforth - Nottingham University Hospitals NHS Trust, Nottingham; T Robinson - Nottingham University Hospitals NHS Trust, Nottingham

Background: Catheter ablation (CA) is the treatment of choice for patients with symptomatic recurrent atrioventricular reciprocating tachycardia, pre-excited atrial fibrillation and for those with asymptomatic pre-excitation with dangerous anterograde accessory pathway (AP) conduction properties.1 CA has a high acute success rate and low complication rate dependent upon AP location. Success rates at follow up are less […]

2 mins
WY Ding (Presenting Author) - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool; PS Yang - Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam; E Jang - Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul; B Joung - Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul; GYH Lip - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool

Background: As the best anthropometric surrogate of visceral adiposity, the effects of abdominal obesity on outcomes of catheter ablation in atrial fibrillation (AF) remain poorly investigated. In this study, we evaluate the effects of abdominal obesity on the long-term efficacy and safety of catheter AF ablation. Methods: We utilised the Korean National Health Insurance cohort […]

6

Oral Abstracts 2 – Arrhythmia Mechanisms

2 mins
V Kanthasamy (Presenting Author) - Barts Heart Centre. Barts Health NHS Trust, London; T Bajomo - Barts Heart Centre. Barts Health NHS Trust, London; N Papageorgiou - Barts Heart Centre. Barts Health NHS Trust, London; C Monkhouse - Barts Heart Centre. Barts Health NHS Trust, London; A Muthumala - Barts Heart Centre. Barts Health NHS Trust, London

Introduction: Chronic high burden of right ventricular (RV) pacing is well known to cause deleterious effects on the left ventricular (LV) systolic function. However, there is variation in this effect with LV systolic function being maintained in some patients and worsening in others. We investigated characteristics amongst a cohort of patients with RV pacing burden […]

2 mins
RK Chattopadhyay (Presenting Author) - Cambridge University Hospitals, Cambridge; A Chousou - Cambridge University Hospitals, Cambridge; R Thomas - Cambridge University Hospitals, Cambridge; J Hughes - Cambridge University Hospitals, Cambridge; J O’Brien - Cambridge University Hospitals, Cambridge; F Pierres - Cambridge University Hospitals, Cambridge; V Vassiliou - University of East Anglia, Norwich; PJ Pugh - Cambridge University Hospitals, Cambridge

Introduction: Pacing-Induced Cardiomyopathy (PICM) can lead to significant morbidity, requiring treatment by device upgrade procedures. The risk of occurrence is directly related to the burden of right ventricular pacing, which can often be reduced by careful device programming. When however frequent ventricular stimulation cannot be avoided, pacing the conduction system may offer an alternative to […]

2 mins
R Davidson (Presenting Author) - Imperial College London, London; KHK Patel - Imperial College London, London; M Brezitski - Imperial College London, London; B Statton - Imperial College London, London; A Berry - Imperial College London, London; X Li - Imperial College London, London; S Purkayastha - Imperial College London, London; J Cousins - Imperial College London, London; D O’Regan - Imperial College London, London; NS Peters - Imperial College London, London; JS Ware - Imperial College London, London; FS Ng - Imperial College London, London

Background: Obesity is associated with pro-arrhythmic electrocardiographic (ECG) abnormalities, such as corrected QT (QTc) prolongation and increased QT dispersion (QTd), which confer a greater risk of ventricular arrhythmia and sudden cardiac death. Few studies have assessed specific measures of repolarisation (T-peak-to-T-end interval (Tpe) or the Tpe/QT, Tpe/QTc, Tpe/JT or Tpe/JTc ratios) in obesity. Owing to greater […]

Background: Uncorrected atrial septal defects (ASD) are associated with atrial arrhythmias however the bi-atrial arrhythmia substrate, and a result, rhythm management strategies, are ill-defined in this cohort. Timely ASD closure may reduce AA prevalence, but the effect of percutaneous ASD closure on AAs has not been systematically evaluated. We aimed to investigate the effects of […]

2 mins
CS Liebers (Presenting Author) - NHLI, London; KHK Patel - NHLI, London; D Aghar-Jaffar - NHLI, London; P Kyriazis - Imperial College London, London; X Li - NHLI, London; R Chowdhury - NHLI, London; NS Peters - NHLI, London; P Punjabi - Imperial College London, London; FS Ng - NHLI, London

Introduction: Obesity which is characterised by excess adipose tissue (AT) has been associated with increased risk of arrhythmia. AT functions as an endocrine organ and secretes adipokines which may induce a proarrhythmic substrate. Specifically, epicardial AT (EAT) has been associated with increased arrhythmic risk and a greater proinflammatory adipokine profile than subcutaneous AT (SAT). Culture […]

2 mins
J Brook (Presenting Author) - Imperial College London, London; A Sufi - Imperial College London, London; D Agha-Jaffar - Imperial College London, London; D Pitcher - Imperial College London, London; BS Handa - Imperial College London, London; NA Qureshi - Imperial College London, London; J Perkins - Royal Veterinary College, University of London, Hertfordshire; A Jothidasan - Harefield Hospital, Harefield; FS Ng - Imperial College London, London; S Harding - Imperial College London, London; AA Bharath - Imperial College London, London; NS Peters - Imperial College London, London; CD Cantwell - Imperial College London, London; RA Chowdhury - Imperial College London, London

Background: Freedom from AF following ablation remains at around 60% even with the addition of electrogram guided procedures alongside pulmonary vein isolation. Gap junctional (GJ) connexin proteins have been established as being deterministic in the development of atrial fibrillation (AF), therefore identifying areas of GJ abnormality (cellular uncoupling) may provide a target to guide ablation […]

7

Oral Abstracts 3 – Devices

2 mins
Jessica Fox (Presenting Author) - Barts Heart Centre, London; L Sevier - Barts Heart Centre, London; M Finlay - Barts Heart Centre, London; J Malcolmson - Barts Heart Centre, London; On behalf of Barts Heart Centre Electrophysiology Department - Barts Heart Centre, London

Introduction: Hypertrophic cardiomyopathy (HCM) is the commonest inherited heart disease. Implantable cardioverter defibrillators (ICDs) are routinely implanted to protect against risk of sudden cardiac death (SCD) in those patients (pts) who meet criteria. Whilst the consequence of not having an ICD when needed is clear, the implantation of cardiac devices is not without short and […]

< 1 min
C Hammond (Presenting Author) - Leeds General Infirmary, Cardiology, Leeds; R Nadarajah - Leeds General Infirmary, Cardiology, Leeds; N Ali - Leeds General Infirmary, Cardiology, Leeds; F Tan - Leeds General Infirmary, Cardiology, Leeds; N Burnet - Leeds General Infirmary, Cardiology, Leeds; C Cole - Leeds General Infirmary, Cardiology, Leeds; M Paton - Leeds General Infirmary, Cardiology, Leeds; R Cubbon - Leeds General Infirmary, Cardiology, Leeds; M Kearney - Leeds General Infirmary, Cardiology, Leeds; J Gierula - Leeds General Infirmary, Cardiology, Leeds; K Witte - Leeds General Infirmary, Cardiology, Leeds; P Patel - Leeds General Infirmary, Cardiology, Leeds

Background: Cardiac resynchronisation therapy (CRT) confers symptomatic and survival benefits in chronic heart failure with reduced ejection fraction (HFrEF). However, there remains a paucity of data on long-term performance of left ventricular pacing leads, including adverse sequelae. Methods: Adult patients receiving CRT for HFrEF between 2008 and 2014 were identified retrospectively from an outpatient electronic […]

2 mins
L Broadhurst (Presenting Author) - Rotherham NHS Foundation Trust, Rotherham; S Smith - Rotherham NHS Foundation Trust, Rotherham; M Smith - Rotherham NHS Foundation Trust, Rotherham

Introduction: Not all patients respond favourably to CRT. Electrical programming may improve CRT response, but a universal programming strategy may be ineffective as patient specific factors can influence electrical timing within the heart. Moreover, there is little guidance for CRT programming, hence CRT devices are often left at suboptimal settings.1 Two emerging technologies, fusion pacing (e.g […]

2 mins
R Dulai (Presenting Author) - East Sussex Healthcare NHS Trust, Eastbourne; S Badiani - East Sussex Healthcare NHS Trust, Eastbourne; RA Veasey - East Sussex Healthcare NHS Trust, Eastbourne; S Furniss - East Sussex Healthcare NHS Trust, Eastbourne; N Patel - East Sussex Healthcare NHS Trust, Eastbourne; N Sulke - East Sussex Healthcare NHS Trust, Eastbourne

Background: Cardiac Contractility Modulation therapy is a novel device-based technology, which may be used in selected heart failure patients. CCM therapy involves applying biphasic, high-voltage (≈7.5 V) and long-duration (≈20 milliseconds) electric signals to the right ventricular septal wall during the absolute myocardial refractory period, which invokes biochemical and cellular changes in the failing myocardium […]

Background: Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure to treat abnormal narrowing of the aortic valve in non-surgical candidates. Rapid ventricular pacing often facilitates optimal positioning of the TAVI valve. Traditionally, this has been Methods: The study was a retrospective service evaluation in sequential patients treated before and after the change from […]

2 mins
D Sharman (Presenting Author) - Northampton General Hospital, Northampton; J Timperley - Northampton General Hospital, Northampton; A Zaidi - Manchester Royal Infirmary, Manchester; E Duncan - University Hospital Bristol, Bristol; F Leyva - University Hospitals Birmingham, Birmingham; N Linker - James Cook University Hospital, Middlesbrough; C Pepper - Leeds Teaching Hospital, Leeds; T Robinson - Nottingham University Hospital, Nottingham; S Sporton - St Bartholomew’s University Hospital, London; K Stromberg - Medtronic, Minnesota; A Pol - Medtronic, Maastricht; P Roberts - Southampton General Hospital, Southampton

Introduction: The Micra post-approval registry (PAR) and Micra Acute Performance regional cohort (MAP; conducted in Europe, Middle East, and Africa [EMEA]) are ongoing prospective registries designed to evaluate safety and performance of the Micra transcatheter pacing system in the post-market real-world setting. The patient profile and implant characteristics of patients undergoing Micra implant in the […]

8

Oral Abstracts 3 – Mapping and Ablation

2 mins
J Elliott (Presenting Author) - St. Bartholomew’s Hospital, London; A Bhuva - St. Bartholomew’s Hospital, London; A Graham - St. Bartholomew’s Hospital, London; N Papageorgiou - St. Bartholomew’s Hospital, London; P Lambiase - St. Bartholomew’s Hospital, London; A Chow - St. Bartholomew’s Hospital, London; C Manisty - St. Bartholomew’s Hospital, London; N Srinivasan - St. Bartholomew’s Hospital, London

Background: Voltage thresholds for ventricular scar definition are based on historic data collected using catheters with widely spaced bipoles. Modern multipolar mapping catheters employ smaller electrodes and interelectrode spacing that theoretically allows for mapping with increased resolution and reduced far-field electrogram (EGM) component. Despite the advancement in technology, historic cutoffs of <0.5 mV for dense […]

2 mins
E Maclean (Presenting Author) - St Bartholomew’s Hospital, London; SM Sukumar - St Bartholomew’s Hospital, London; The EP Department at Barts Heart Centre - St Bartholomew’s Hospital, London

Introduction: The Barts Heart Centre was established in May 2015. Trends in EP procedural workflow and complications were examined as part of continuous audit. Methods: Procedural data were extracted from an internal database of all electrophysiology procedures (EP studies and ablations) performed between 1st January 2016 and 1st January 2020. Procedure reports and clinical records […]

2 mins
DR Paris (Presenting Author) - BardyDx, Seattle, WA; GH Bardy - BardyDx, Seattle, WA; RL Boleyn - BardyDx, Seattle, WA; EM Dreisbach - BardyDx, Seattle, WA; CF Dulken - BardyDx, Seattle, WA; SJ Blancher - Virginia Mason, Seattle, WA; M Wang - BardyDx, Seattle, WA

Background: The identification of atrial fibrillation (AF) using artificial intelligence (AI), either with medically prescribed ECG monitors or non-prescription devices such as watches, is not to be taken lightly. Little focus has been placed on the cost, anxiety and potential therapeutic consequences of a false positive diagnosis. The potential value of AI in AF diagnostics is […]

< 1 min
M Orini (Presenting Author) - Barts Heart Centre, London; A Seraphim - Barts Heart Centre, London; A Graham - Barts Heart Centre, London; A Bhuva - Barts Heart Centre, London; E Zacur - Oxford University, Oxford; P Kellman - National Institutes of Health, Bethesda; R Schilling - Barts Heart Centre, London; R Hunter - Barts Heart Centre, London; M Dhinoja - Barts Heart Centre, London; M Finlay - Barts Heart Centre, London; S Ahsan - Barts Heart Centre, London; A Chow - Barts Heart Centre, London; J Moon - Barts Heart Centre, London; C Manisty - Barts Heart Centre, London; PD Lambiase - Barts Heart Centre, London

Aims: Scar evaluation by late gadolinium enhancement cardiovascular magnetic resonance (LGE-CMR) can assist ventricular tachycardia (VT) ablation, but co-registration with electro-anatomical maps (EAMs) and imaging artefact from implantable cardioverter defibrillators (ICDs) limit accuracy. We assessed the feasibility of using personalised co-registration algorithms to correlate low-voltage zones (LVZ) with optimised LGE-CMR scar imaging in patients with […]

2 mins
RP Dowd (Presenting Author) - University Hospitals Coventry & Warwickshire, Coventry; R Proietti - Department of Cardiac, Thoracic, Vascular Sciences, and University of Padua, Padova; VG Lim - University Hospitals Coventry & Warwickshire, Coventry; H Salim - University Hospitals Coventry & Warwickshire, Coventry; B Aldhoon - Worcestershire Royal Hospital, Worcester; W Foster - Worcestershire Royal Hospital, Worcester; A Merghani - University Hospitals Coventry & Warwickshire, Coventry; M Kuehl - University Hospitals Coventry & Warwickshire, Coventry; S Yusuf - University Hospitals Coventry & Warwickshire, Coventry; S Panikker - University Hospitals Coventry & Warwickshire, Coventry; S Hayat - University Hospitals Coventry & Warwickshire, Coventry; F Osman - University Hospitals Coventry & Warwickshire, Coventry; P Banerjee - University Hospitals Coventry & Warwickshire, Coventry; K Patel - University Hospitals Coventry & Warwickshire, Coventry; N Lellouche - Hopital Henri Mondor Albert Chenevier, Paris; T Dhanjal - University Hospitals Coventry & Warwickshire, Coventry

Background: Ventricular Tachycardia (VT) mapping strategies for scar-dependent monomorphic VT have traditionally involved entrainment and pace mapping. The increasing importance of substrate mapping has emerged with several methods described to target the VT site of origin and diastolic conduction channels (CCs), such as, low amplitude ventricular activity (LAVA) potential and decrementing evoked potential (DEEP) mapping. […]

2 mins
M Leo (Presenting Author) - Oxford University Hospitals NHS Foundation Trust, Oxford; M Pedersen - Oxford University Hospitals NHS Foundation Trust, Oxford; K Rajappan - Oxford University Hospitals NHS Foundation Trust, Oxford; M Ginks - Oxford University Hospitals NHS Foundation Trust, Oxford; R J Hunter - Barts Heart Centre, London; R Bowers - Hampshire Hospitals NHS Foundation Trust, Hampshire; M Kalla - Queen Elisabeth Hospital, Birmingham; Y Bashir - Oxford University Hospitals NHS Foundation Trust, Oxford; T R Betts - Oxford University Hospitals NHS Foundation Trust, Oxford

Background: Low radiofrequency (RF) powers are commonly used on the posterior wall of the left atrium (LA) for atrial fibrillation (AF) ablation to prevent oesophageal damage. Compared with higher powers, they require longer ablation durations to achieve a target lesion size index (LSI). Oesophageal heating during ablation is the result of a time-dependent process of […]

9

Best Posters

< 1 min
S Griffiths (Presenting Author) - Royal Brompton Hospital, London; J Behar - Royal Brompton Hospital, London; M Debney - Royal Brompton Hospital, London; C Monkhouse - Barts Heart Centre, London; M Lowe - Barts Heart Centre, London; E Cantor - Royal Brompton Hospital, London; V Boyalla - Royal Brompton Hospital, London; N Karim - Royal Brompton Hospital, London; J Till - Royal Brompton Hospital, London; V Markides - Royal Brompton Hospital, London; J Clague - Royal Brompton Hospital, London; T Wong - Royal Brompton Hospital, London

Background: The conventional route to insert cardiac implantable electronic devices (CIED) is not always possible. Devices implanted via the femoral route (F-CIED) remain an alternative option despite the advent of leadless and subcutaneous devices. However, the long-term outcomes of F-CIED, in particular complex F-CIED (implantable cardioverter defibrillators (ICD) and cardiac resynchronisation therapy (CRT) devices)), are not […]

2 mins
SK Kamalathasan (Presenting Author) - Pinderfields General Hospital, Wakefield; JW Wren - Pinderfields General Hospital, Wakefield; VK Nayar - Pinderfields General Hospital, Wakefield

Background: CRT improves prognosis in selected patients with systolic heart failure (HF). There is a paucity of data regarding longer-term outcomes in octogenarians who receive CRT. Purpose: To evaluate long-term morbidity, mortality and guideline-based HF treatment in an octogenarian cohort of CRT recipients. Methods: Retrospective analysis of 30 patients aged ≥80 years old who underwent […]

2 mins
AM Adlan (Presenting Author) - Liverpool Heart & Chest Hospital, Liverpool; CM Pearman - Liverpool Heart & Chest Hospital, Liverpool; M Obeidat - Liverpool Heart & Chest Hospital, Liverpool; C Pius - Liverpool Heart & Chest Hospital, Liverpool; A Ajay - Liverpool Heart & Chest Hospital, Liverpool; P Biju - Liverpool Heart & Chest Hospital, Liverpool; S Dalvi - Liverpool Heart & Chest Hospital, Liverpool; P Modi - Liverpool Heart & Chest Hospital, Liverpool; M Hall - Liverpool Heart & Chest Hospital, Liverpool; MJ Wright - Liverpool Heart & Chest Hospital, Liverpool

Introduction: Conduction tissue damage during cardiac surgery necessitates permanent pacemaker (PPM) implantation in approximately 4% of patients. Studies have demonstrated late recovery of conduction in 16-42% of patients, but the time course is unknown. It is also unclear whether the presence of an underlying rhythm (ULR) at the time of implant predicts late recovery. We […]

2 mins
MM Sanghvi (Presenting Author) - Barts Heart Centre, London; DM Jones - Barts Heart Centre, London; C Monkhouse - Barts Heart Centre, London; V Kanthasamy - Barts Heart Centre, London; R Providencia - Barts Heart Centre, London; S Sporton - Barts Heart Centre, London; MJ Earley - Barts Heart Centre, London; M Finlay - Barts Heart Centre, London

Introduction: Implantable Loop Recorder (ILR) procedures are now done by allied health professionals in outpatients; however, it is expensive with a single device costing £3,878. This is in spite of limited evidence regarding the diagnostic utility of ILR so we performed a detailed examination of its performance in the real-world. Methods: The detailed clinical records […]

2 mins
CU Peter (Presenting Author) - Nottingham University Hospitals, Nottingham; M Hall - Nottingham University Hospitals, Nottingham; J Chuen - Nottingham University Hospitals, Nottingham; AD Staniforth - Nottingham University Hospitals, Nottingham; T Robinson - Nottingham University Hospitals, Nottingham

Introduction: The ELECTRa registry indicated lower success rates and higher complication rates in low volume centres performing <30 transvenous lead extractions (TLE) per year. The UK lead extraction group met in 2018 to produce standards for lead extraction classifying procedures as low, medium or high risk. It recommended having a cardiac surgical team present for […]

2 mins
SK Musiol (Presenting Author) - Bristol Heart Institute, Bristol; K Mansfield - Bristol Heart Institute, Bristol; K Maciver - Bristol Heart Institute, Bristol; R Marriott - Bristol Heart Institute, Bristol; P Barman - Bristol Heart Institute, Bristol

Introduction: Catheter ablation is the treatment of choice for accessory pathways (APs). Currently, it is unclear whether the use of electro-anatomical mapping (EAM) systems results in better outcomes of radiofrequency (RF) AP ablations. To help answer this question we present a retrospective observational analysis of a modern single centre cohort. Methods: Clinical and electrophysiological data […]

10

Posters

2 mins
L Priestman (Presenting Author) - Taunton and Somerset NHS Trust, Taunton; C Sowerby - Taunton and Somerset NHS Trust, Taunton; G Furniss - Taunton and Somerset NHS Trust, Taunton; M Dayer - Taunton and Somerset NHS Trust, Taunton

Our trust recently replaced our defibrillators with the Zoll R Series Plus. This has a rectilinear biphasic waveform. Compared with traditional energies used with monophasic waveforms, the Zoll literature recommends lower energies for synchronised DC cardioversion of arrhythmias, starting at 75J (75J, 120J, 150J, 200J), based upon the results of clinical trials; the recommendations are to […]

2 mins
Y Guo (Presenting Author) - Medical School of Chinese PLA, Department of Cardiology, Chinese PLA General Hospital, Beijing, China; Liverpool Centre for Cardiovascular Sciences, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom, Beijing; Y Wang - Chinese PLA General Hospital, Beijing; GYH Lip - Medical School of Chinese PLA, Department of Cardiology, Chinese PLA General; Hospital, Beijing, China; Liverpool Centre for Cardiovascular Sciences, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Background: Elderly patients with atrial fibrillation (AF) may present with acute thromboembolic events, often in combination with high bleeding risk. There are limited data on such high-risk patients from China, as well as the benefits and harms of oral anticoagulants (OAC). Objective: To investigate the impacts on death, thromboembolism (TE), and acute coronary artery syndrome […]

2 mins
WY Ding (Presenting Author) - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool; GYH Lip - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool; D Pastori - Department of Clinical, Internal Medicine, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome; A Shantsila - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool

Background: Atrial fibrillation (AF) and chronic kidney disease (CKD) are closely related conditions that are both associated with a significant increase in major adverse cardiovascular events (MACE). The objectives of this study were to evaluate the impact of CKD on MACE in patients with AF and the predictive value of the 2MACE score. Methods: We […]

2 mins
AJ Bull (Presenting Author) - Liverpool Heart and Chest, Liverpool; F Frost - Liverpool Heart and Chest, Liverpool; D Nazareth - Liverpool Heart and Chest, Liverpool; D J Wright - Liverpool Heart and Chest, Liverpool

Background: Pneumothorax is an important early complication of cardiac pacemaker implantation however little is known about the modern incidence and outcomes. Current guidelines do not distinguish between causes of iatrogenic pneumothorax and so procedure specific data is needed to help guide cardiologists and respiratory clinicians alike. Method: Retrospective analysis of patients who developed a pneumothorax […]

2 mins
C Monteiro (Presenting Author) - University of Oxford, Oxford; D Webster - Oxford University Hospitals NHS Foundation Trust, Oxford; J Ormerod - Oxford University Hospitals NHS Foundation Trust, Oxford; T Betts - Oxford University Hospitals NHS Foundation Trust, Oxford

Background: Delivery of cardiac resynchronisation therapy (CRT) using conventional systems can be limited by sub-optimal venous anatomy. The WiSE-CRT (EBR Systems, Sunnyvale, CA, USA) has been approved for use with existing right-sided systems. We report the case of a CRT recipient with a left ventricular (LV) lead in the middle cardiac vein (MCV) and who subsequently […]

2 mins
C Voukalis (Presenting Author) - Institute of Cardiovascular Sciences, University of Birmingham, Birmingham; E Shantsila - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool; GYH Lip - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool

Background: Pneumothorax is an important early complication of cardiac pacemaker implantation however little is known about the modern incidence and outcomes. Current guidelines do not distinguish between causes of iatrogenic pneumothorax and so procedure specific data is needed to help guide cardiologists and respiratory clinicians alike Method: Retrospective analysis of patients who developed a pneumothorax […]

2 mins
LA Ritchie (Presenting Author) - University of Liverpool, Liverpool; O Oke - University of Liverpool, Liverpool; SL Harrison - University of Liverpool, Liverpool; SE Rodgers - University of Liverpool, Liverpool; GYH Lip - University of Liverpool, Liverpool; DA Lane - University of Liverpool, Liverpool

Introduction: Atrial fibrillation (AF) disproportionately affects older people and the incidence of previously undiagnosed AF in long-term care (LTC) residents is high (approximately 14%). Prescription of oral anticoagulation (OAC) is integral to stroke prevention for AF but there is evidence of under-treatment in older people in LTC, likely due to clinicians’ concerns of iatrogenic harm […]

2 mins
PS Burdett - Liverpool Centre for Cardiovascular Science, Liverpool Health Partners, Liverpool, United Kingdom; GYH Lip - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool

Background: Atrial fibrillation (AF) is the most common sustained heart arrhythmia and a major preventable cause of stroke, heart failure and dementia. AF already accounts for a significant amount of NHS funding, and over the coming years is highly likely to impose a growing cost on NHS budgets and the wider UK health care system. […]

2 mins
WYD Ding (Presenting Author) - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool; GYH Lip - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool; SB Bartoletti - Liverpool Heart & Chest Hospital, Liverpool; LM Morrison - Liverpool Heart & Chest Hospital, Liverpool; AK Khalatbari - Liverpool Heart & Chest Hospital, Liverpool; SA Aggarwal - Liverpool Heart & Chest Hospital, Liverpool; PV Velavan - Liverpool Heart & Chest Hospital, Liverpool; DG Gupta - Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool

Background: The presence of left atrial appendage (LAA) thrombus precludes endocardial LAA occlusion, but there are scant data on the management of these very high-risk atrial fibrillation (AF) patients. Our aim was to evaluate the efficacy and safety of short-term apixaban treatment for LAA thrombi detected prior to planned LAA occlusion in patients with contraindications […]

2 mins
ME Taylor (Presenting Author) - Freeman Hospital, Newcastle; JP Bourke - Freeman Hospital, Newcastle; M Das - Freeman Hospital, Newcastle

Introduction: Cryoballoon is an effective treatment for atrial fibrillation and is conventionally guided by fluoroscopy with contrast venography to confirm pulmonary vein (PV) occlusion.  The Kodex-EDP system (EDP Solutions, Philips) is a novel non-contact navigation and mapping system using the unique dielectric properties of biological tissue.  The system measures the varying potentials induced on standard […]

2 mins
YR Hill (Presenting Author) - University of Exeter, Exeter; DR Tomlinson - University Hospitals Plymouth NHS Trust, Plymouth

Introduction: Successful pulmonary vein isolation (PVI) requires the creation of continuous and durable transmural ablation lesions encircling the pulmonary veins (PV). During contact force (CF) radiofrequency (RF) delivery, catheter stability is clearly an important determinant of lesion creation. However, the precise extent to which cardiac and respiratory motion influence site-specific RF effects is presently unknown. […]

2 mins
R Dulai (Presenting Author) - Cardiology Research Department, Eastbourne District General Hospital, East Sussex Hospitals NHS Trust, UK, Eastbourne; N Freemantle - Institute of Clinical Trials and Methodology, University College London, UK, London; C Sugihara - Maidstone and Tunbridge Wells NHS Trust, UK, Maidstone ; S Podd - The Royal Devon and Exeter NHS Foundation Trust, UK, Exeter; W Eysenck - Cardiology Research Department, Eastbourne District General Hospital, East Sussex Hospitals NHS Trust, UK, Eastbourne; M Lewis - Brighton and Sussex University Hospitals NHS Trust, UK, Brighton; J Hyde - Brighton and Sussex University Hospitals NHS Trust, UK, Brighton; R A Veasey - Cardiology Research Department, Eastbourne District General Hospital, East Sussex Hospitals NHS Trust, UK, Eastbourne; S Furniss - Cardiology Research Department, Eastbourne District General Hospital, East Sussex Hospitals NHS Trust, UK, Eastbourne; N Sulke - Cardiology Research Department, Eastbourne District General Hospital, East Sussex Hospitals NHS Trust, UK, Eastbourne

Introduction: Catheter ablation has been shown to be safe and effective in reducing atrial fibrillation (AF) burden and symptoms. However, there is limited long term data using continuous monitoring to assess the actual success of catheter ablation. This study assessed the long-term outcome of AF ablation in patients with implantable cardiac devices allowing beat-to-beat analysis […]

2 mins
K Saleh (Presenting Author) - Frimley Park Hospital, Frimley; L Watts - Frimley Park Hospital, Frimley; E Hipwell - Frimley Park Hospital, Frimley; M Faircloth - Frimley Park Hospital, Frimley

Introduction: Atrial fibrillation (AF) is a common arrhythmia in the intensive care setting. Observational studies of patients who develop new-onset AF during critical illness have demonstrated an increased risk of recurrence and increased morbidity and mortality, in both the short and long term, related to thromboembolic stroke and heart failure. Patients with new-onset AF on the […]

< 1 min
Peter Waddingham (Presenting Author) - St Bartholomew’s Hospital, Barts Health NHS Trust, London; A Creta - St Bartholomew’s Hospital, Barts Health NHS Trust, London; ASC Dennis - St Bartholomew’s Hospital, Barts Health NHS Trust, London; MJ Earley - St Bartholomew’s Hospital, Barts Health NHS Trust, London; P Moore - St Bartholomew’s Hospital, Barts Health NHS Trust, London; A Muthumala - St Bartholomew’s Hospital, Barts Health NHS Trust, London; AWC Chow - St Bartholomew’s Hospital, Barts Health NHS Trust, London

Aims: Cardiac perforations caused by pacemaker and implantable-cardioverter defibrillator (ICD) leads are serious events. Due in part to their infrequency, management options and outcomes are unclear. Methods: A single-centre retrospective study was conducted at a high-volume tertiary centre to identify patients in whom cardiac perforation occurred due to lead implantation or intervention. The search included […]

2 mins
U Ding (Presenting Author) - Sheffield Teaching Hospitals NHS Trust, Sheffield; S Hunter - Sheffield Teaching Hospitals NHS Trust, Sheffield; P Braidley - Sheffield Teaching Hospitals NHS Trust, Sheffield; N Briffa - Sheffield Teaching Hospitals NHS Trust, Sheffield; N Cartwright - Sheffield Teaching Hospitals NHS Trust, Sheffield; J Lee - Sheffield Teaching Hospitals NHS Trust, Sheffield

Introduction: Surgical “Maze” was first performed in 1987, although techniques have evolved since then. The most recent 2017 Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation (AF) recommends concomitant ablation for symptomatic AF alongside other cardiac surgery (Class I/IIa) and standalone ablation (Class IIa) for persistent and long-standing persistent AF. We sought […]

2 mins
G Dimitropoulos (Presenting Author) - University Hospital of Birmingham NHS Trust, Birmingham; N Shah - University Hospital of Birmingham NHS Trust, Birmingham; M Kalla - University Hospital of Birmingham NHS Trust, Birmingham; S Flannigan - University Hospital of Birmingham NHS Trust, Birmingham; HJ Marshall - University Hospital of Birmingham NHS Trust, Birmingham; J De Bono - University Hospital of Birmingham NHS Trust, Birmingham

Introduction: Transvenous lead extraction (TLE) of cardiac implantable devices has been established as a safe and effective practice. Despite the advancement of methods and techniques, there is still a wide variation amongst centres. We present our own experience from 10 years of TLE procedures at the University Hospital of Birmingham. Methods: We retrospectively analysed the […]

2 mins
H Granville (Presenting Author) - Barts Health NHS Trust, London; C Monkhouse - Barts Health NHS Trust, London; S Jones - Barts Health NHS Trust, London

Background: Remote monitoring (RM) for implanted cardiac devices has been increasing nationally. At a large tertiary cardiac centre with more than 5,000 patients enrolled on RM, a significant problem is disconnected RM. Disconnected RM can be detrimental, resulting in undetected arrhythmia, battery depletion or lead failure, all of which can result in deterioration in health or […]

2 mins
L Leung (Presenting Author) - St. George’s NHS Trust, London; A Elbatran - St. George’s NHS Trust, London; G Dhillon - St. George’s NHS Trust, London; A Bajpai - St. George’s NHS Trust, London; A Li - St. George’s NHS Trust, London; M Norman - St. George’s NHS Trust, London; R Kaba - St. George’s NHS Trust, London; M Sohal - St. George’s NHS Trust, London; Z Akhtar - St. George’s NHS Trust, London; B Evranos - St. George’s NHS Trust, London; H Gonna - St. George’s NHS Trust, London; I Harding - St. George’s NHS Trust, London; N Al Subaie - Kuwait Oil Company Ahmadi Hospital, Kuwait ; J Louis-Auguste - St. George’s NHS Trust, London; J Hayat - St. George’s NHS Trust, London; MM Gallagher - St. George’s NHS Trust, London

Background: The IMPACT study established the role of esophageal temperature control in preventing esophageal injury during radiofrequency (RF) ablation for atrial fibrillation (AF). The procedures were performed using Ablation Index (AI) technology. Objective: To determine the effect of esophageal cooling on the formation of RF lesions and the characteristics of RF lesions associated with esophageal […]

2 mins
M Leo (Presenting Author) - Oxford University Hospitals NHS Foundation Trust, Oxford; A Banerjee - University of Oxford, Oxford; A Briosa e Gala - Oxford University Hospitals NHS Foundation Trust, Oxford ; M Pope - Oxford University Hospitals NHS Foundation Trust, Oxford ; R J Hunter - Barts Heart Centre, London; T R Betts - Oxford University Hospitals NHS Foundation Trust, Oxford

Background: Reliable creation of durable transmural lesions is the key for successful catheter ablation procedures. Tissue impedance drop during radiofrequency delivery has been traditionally used as an indicator of lesion formation and size. More recently, Lesion Size Index (LSI) has become available in clinical settings as marker of lesion formation. In animal studies LSI correlates […]

2 mins
PA Chousou (Presenting Author) - Cambridge University Hospital, Cambridge; RK Chattopadhyay - Cambridge University Hospital, Cambridge; R Thomas - Cambridge University Hospital, Cambridge J Hayes - Cambridge University Hospital, Cambridge; J O’Brien - Cambridge University Hospital, Cambridge; F Pierres - Cambridge University Hospital, Cambridge; V Vassiliou - University of East Anglia, Norwich; PJ Pugh - Cambridge University Hospital, Cambridge

Introduction: Current guidelines indicate that pacing methods that maintain physiologic ventricular activation (biventricular pacing or His-bundle pacing) should be chosen over right ventricular pacing among patients with EF 36-50% who are expected to require ventricular pacing >40% of the time. There are no guidelines to help predict which patients will receive a high burden of […]

< 1 min
PH Waddingham (Presenting Author) - St Bartholomew’s Hospital, Barts Health NHS Trust, London; M Orini - St Bartholomew’s Hospital, Barts Health NHS Trust, London; J Mangual - Abbott, Sylmar; A Muthumala - St Bartholomew’s Hospital, Barts Health NHS Trust, London; S Sporton - St Bartholomew’s Hospital, Barts Health NHS Trust, London; PD Lambiase - St Bartholomew’s Hospital, Barts Health NHS Trust, London; AWC Chow - St Bartholomew’s Hospital, Barts Health NHS Trust, London

Background: Cardiac resynchronization therapy (CRT) with MultiPoint Pacing (MPP) can improve electrical resynchronization of the left ventricle (LV) compared to conventional CRT. The SyncAV™ algorithm dynamically combines intrinsic atrioventricular (AV) conduction with pacing, improving electrical synchrony. The study objectives included assessment of the change in electrical synchrony with SyncAV and MPP, using non-invasive mapping with electrocardiographic […]

2 mins
A Elsayed (Presenting Author) - Glenfield Hospital, Leicester; A Abouzaid - Glenfield Hospital, Leicester; K Balasundaram - Glenfield Hospital, Leicester; A Shah - Glenfield Hospital, Leicester; M Ibrahim - Glenfield Hospital, Leicester

Background: Atrial fibrillation (AF) is the most common sustained arrhythmia in adult population with increased prevalence particularly in elderly. AV node ablation and pacemaker insertion (ablate and pace) is a widely accepted strategy for heart rate control in patients with symptomatic AF when rhythm control strategy fails or is deemed inappropriate. Patients usually receive a […]

< 1 min
A Creta (Presenting Author) - Barts Heart Centre, London; R Providencia - Barts Heart Centre, London; N Papageorgiou - Barts Heart Centre, London; R Ang - Barts Heart Centre, London; RJ Hunter - Barts Heart Centre, London; MJ Earley - Barts Heart Centre, London; MD Lowe - Barts Heart Centre, London; S Sporton - Barts Heart Centre, London; N Worthington - Abbott, London; J Williams - Abbott, London; RJ Schilling - Barts Heart Centre, London; PD Lambiase - Barts Heart Centre, London; AW Chow - Barts Heart Centre, London

Introduction: Complex atrial tachycardias (AT) are frequently encountered in patients after left atrial catheter abaltions. We aimed to evaluate the HD grid technology for high-resolution mapping of these challenging arrhythmias. Methods: Prospective observational study including consecutive patients undergoing de novo or redo catheter ablation for AT. Electroanatomical mapping during AT was performed using the Advisor […]

2 mins
HJ Williams (Presenting Author) - Gloucestershire Hospitals NHS Foundation Trust, Gloucester; J Gough - Gloucestershire Hospitals NHS Foundation Trust, Gloucester; A Kitchin - Gloucestershire Hospitals NHS Foundation Trust, Gloucester; N Vaidya - Gloucestershire Hospitals NHS Foundation Trust, Gloucester; R Bond - Gloucestershire Hospitals NHS Foundation Trust, Gloucester

Background: DC cardioversion (DCCV) is commonly used to assess the symptomatic benefit of sinus rhythm (SR) when deciding whether to offer further rhythm control therapies such as AF ablation. However, acute failure of DCCV to achieve SR and early reversion to AF are common. This makes assessment of the symptomatic benefit of SR very difficult and […]

2 mins
L Broadhurst (Presenting Author) - Rotherham NHS Foundation Trust, Rotherham

Introduction: It is widely accepted that the methods for optimising CRT vary in clinical practice. Electrical optimisation of CRT is becoming more popular with QRS narrowing and favourable ECG characteristics emerging as markers of success (1). The aim of this survey was to gauge current working practices of CRT within the UK and Ireland, with […]

2 mins
LY Lei (Presenting Author) - University of Calgary, Calgary; PT Pollak - University of Calgary, Calgary; DS Chew - Duke Clinical Research Institute, Durham; R Furlan - Humanitas Clinical and Research Center, Rozzano; E Ilhan - University of Calgary, Calgary; W Lee - University of Calgary, Calgary; Z Meng - Dalhousie University, Halifax; RS Sheldon - University of Calgary, Calgary; SR Raj - University of Calgary, Calgary

Introduction: Atrial fibrillation (AF) is the most frequently encountered sustained arrhythmia. Electrical cardioversion is incompletely effective yet requires sedation and in-hospital monitoring. A “pill-in-the-pocket” Class IC anti-arrhythmic drug approach is often successful in restoring sinus rhythm but is limited by contraindications and safety concerns. This systematic review assessed the efficacy of single, high-dose oral amiodarone […]

2 mins
L Broadhurst (Presenting Author) - Rotherham NHS Foundation Trust, Rotherham; S Smith - Rotherham NHS Foundation Trust, Rotherham; M Smith - Rotherham NHS Foundation Trust, Rotherham

Introduction: Accurate measurement of QRS duration is crucial in CRT to identify eligible patients. Furthermore, QRS narrowing is emerging as a key marker of successful CRT with a growing evidence base of improved response and long-term survival. Despite this, there is no agreed technique to measure QRS duration and different methods are used in clinical […]

2 mins
S Dalvi (Presenting Author) - Liverpool Heart and Chest Hospital NHS, Liverpool; H Cook - Liverpool Heart and Chest Hospital NHS, Liverpool; A Adlan - Liverpool Heart and Chest Hospital NHS, Liverpool; M Hall - Liverpool Heart and Chest Hospital NHS, Liverpool; A Rao - Liverpool Heart and Chest Hospital NHS, Liverpool

Background: Leadless pacemakers were developed as an alternative pacing modality in patients who cannot undergo transvenous pacing. Early data suggested a good safety and efficacy profile, however real-world data is limited. Purpose: To report our single tertiary centre experience in leadless pacemaker implantation. Methodology: All consecutive patients who underwent leadless pacemaker implantation at Liverpool Heart […]

2 mins
S Griffiths (Presenting Author) - Royal Brompton Hospital, London; K Evangelista - Royal Brompton Hospital, London; K Lascelles - Royal Brompton Hospital, London

Introduction: Coronavirus disease 2019 (COVID-19) has presented unparalled challenges to the management of patients with cardiac implantable electronic devices (CIED). The need to limit exposure to healthcare staff and patients has increased reliance on remote monitoring (RM). This study summarises the change in workload of a device clinic in a Tertiary centre required to completely […]

2 mins
AM Mehta (Presenting Author) - King’s College London, London; ML Beach - King’s College London, London; I Sim - King’s College London, London; C Corrado - King’s College London, London; R Benidikas - King’s College London, London; JA Solis-Lemus - King’s College London, London; O Razeghi - King’s College London, London; J Whitaker - King’s College London, London; L O’Neill - King’s College London, London; G Plank - University of Graz, Graz; EJ Vigmond - LIRYC University of Bordeaux, Bordeaux; SE Williams - King’s College London, London; MD O’Neill - King’s College London, London; CH Roney - King’s College London, London; SA Niederer - King’s College London, London

Introduction: Radiofrequency catheter ablation therapy for atrial fibrillation (AF) patients ranges from pulmonary vein isolation (PVI) to more extensive ablation strategies consisting of PVI together with multiple additional lesions. AF patients represent a diverse population requiring a range of different treatment approaches; no single approach is right for all patients, with many patients responding to […]

2 mins
G Dimitropoulos (Presenting Author) - University Hospital Birmingham NHS Trust, Birmingham; A Chambers - University Hospital Birmingham NHS Trust, Birmingham; M Lencioni - University Hospital Birmingham NHS Trust, Birmingham; J De Bono - University Hospital Birmingham NHS Trust, Birmingham; HJ Marshall - University Hospital Birmingham NHS Trust, Brimingham; T Betts - Oxford University Hospital, Oxford; M Kalla - University Hospital Birmingham NHS Trust, Birmingham

Background/Introduction: The role of pulmonary veins (PVs) in triggering Atrial Fibrillation (AF) is well established. The diameter and morphological features of the PVs in relationship to AF have been studied in animal and human models. The PV sleeve length has not been characterised in vivo in patients undergoing AF ablation. We hypothesised that left atrial […]

< 1 min
LM McMahon - Ulster University, Belfast; CJ Breen (Presenting Author) - Ulster University, Belfast

Background/Objectives: Pacemakers detect subclinical atrial fibrillation that may be a predictor of risk of stroke. Evidence for the efficacy of algorithms for prevention and treatment of atrial fibrillation is controversial. The aim is to systematically review current evidence on the efficacy of atrial anti-tachycardia pacing (a-ATP) and atrial prevention (APP) algorithms in the reduction of […]

< 1 min
Peter Waddingham (Presenting Author) - St Bartholomew’s Hospital, Barts Health NHS Trust, London; M Orini - St Bartholomew’s Hospital, Barts Health NHS Trust, London; J Mangual - Abbott, Sylmar; A Muthumala - St Bartholomew’s Hospital, Barts Health NHS Trust, London; S Sporton - St Bartholomew’s Hospital, Barts Health NHS Trust, London; PD Lambiase - St Bartholomew’s Hospital, Barts Health NHS Trust, London; AWC Chow - St Bartholomew’s Hospital, Barts Health NHS Trust, London

Background: MultiPoint Pacing (MPP) CRT may improve electrical resynchronization of the left ventricle (LV). Optimization with SyncAV dynamically combines intrinsic atrioventricular (AV) conduction and pacing. Objective: To assess regions of fixed and functional conduction block in patients with LBBB and the impact of MPP & SyncAV, evaluated by electrocardiographic imaging (ECGi). Methods: Patients in sinus […]

2 mins
N Ahluwalia (Presenting Author) - St Bartholomew’s Hospital, London; A Graham - St Bartholomew’s Hospital, London; M Orini - University College London, London; JS Gill - St Bartholomew’s Hospital, London; S Sporton - St Bartholomew’s Hospital, London; A Chow - St Bartholomew’s Hospital, London; RJ Hunter - St Bartholomew’s Hospital, London; P Lambiase - St Bartholomew’s Hospital, London; M Dhinoja - St Bartholomew’s Hospital, London

Introduction: Ventricular tachycardia (VT) storm is a medical emergency characterised by clustered episodes of ventricular arrhythmia seen in patients with structurally abnormal hearts. Effective management of this complex, life-threatening phenomenon requires an understanding of arrhythmia mechanisms and the multi-modality treatment options. Although ablation can be life-saving, it is associated with significant risk in this sick […]

2 mins
N Ahluwalia (Presenting Author) - St Bartholomew’s Hospital, London; A Graham - St Bartholomew’s Hospital, London; M Orini - St Bartholomew’s Hospital, London; D Pang - St Bartholomew’s Hospital, London; S Sporton - St Bartholomew’s Hospital, London; A Chow - St Bartholomew’s Hospital, London; RJ Hunter - St Bartholomew’s Hospital, London; P Lambiase - St Bartholomew’s Hospital, London; M Dhinoja - St Bartholomew’s Hospital, London

Introduction: Retrospective studies have demonstrated catheter ablation can reduce premature ventricular complex (PVC) burden. However, the association between objective and patient reported outcomes is unclear, with reporting on the latter particularly limited. The aim of this study was to measure and correlate objective and subjective outcomes of patients undergoing PVC ablation for symptomatic benefit. Methods: […]

2 mins
H Wilburn (Presenting Author) - Rotherham General Hospital, Rotherham; L Broadhurst - Rotherham General Hospital, Rotherham; S Smith - Rotherham General Hospital, Rotherham

Introduction: Cardiac resynchronisation therapy (CRT) is used in select heart failure patients1,2 to improve quality of life and mortality.3-5 Some patients are reported to experience no benefit; so called ‘non-responders’. This retrospective service evaluation aimed to determine the CRT response rate at Rotherham General Hospital (RGH), exploring which variables may be influencing response. Methods: Medical […]

2 mins
T Lobban MBE (Presenting Author) - Arrhythmia Alliance, Chipping Norton; S Kempton -; Arrhythmia Alliance, Chipping Norton; N Breakwell - Arrhythmia Alliance, Chipping Norton

Summary: Arrhythmias affect more than two million people every year in the UK (NHS, 2018). Atrial Fibrillation (AF) is the most common cardiac arrhythmia, with over 1.5 million people diagnosed, however approximately 500,000 individuals remain undiagnosed, and at risk of suffering a life-threatening, debilitating AF-related stroke. It is paramount that these individuals are anticoagulated effectively […]

2 mins
T Ganeswaran (Presenting Author) - Barts Heart Centre, London; R Mravljak - Barts Heart Centre, London; H Page - Barts Heart Centre, London; S Jones - Barts Heart Centre, London; C Monkhouse - Barts Heart Centre, London

Introduction: COVID-19 (C19) is a novel coronavirus characterised as a severe acute respiratory syndrome. The UK government advised the cancellation of elective procedures in March 2020 to reduce virus transmission and to increase intensive care capacity. Several risk factors, including cardiovascular disease (CVD), have been shown to increase vulnerability to C19. In light of new […]

Introduction: Hypertrophic cardiomyopathy (HCM) is the commonest inherited heart disease. Implantable cardioverter defibrillators (ICDs) are routinely implanted to protect against risk of sudden cardiac death (SCD) in those patients who meet criteria. Whilst the consequence of not having an ICD when needed is clear, the implantation of cardiac devices is not without short and long-term […]

2 mins
R Dulai (Presenting Author) - Cardiology Research Department, East Sussex Hospitals NHS Trust, Eastbourne District General Hospital, Eastbourne; A Chilmeran - Cardiology Research Department, East Sussex Hospitals NHS Trust, Eastbourne District General Hospital, Eastbourne; M Hassan - Cardiology Research Department, East Sussex Hospitals NHS Trust, Eastbourne District General Hospital, Eastbourne; RA Veasey - Cardiology Research Department, East Sussex Hospitals NHS Trust, Eastbourne District General Hospital, Eastbourne; S Furniss - Cardiology Research Department, East Sussex Hospitals NHS Trust, Eastbourne District General Hospital, Eastbourne; N Patel - Cardiology Research Department, East Sussex Hospitals NHS Trust, Eastbourne District General Hospital, Eastbourne; N Sulke - Cardiology Research Department, East Sussex Hospitals NHS Trust, Eastbourne District General Hospital, Eastbourne

Background: Cardiac contractility modulation (CCM)  is a new device based technology which  applies non-excitatory electrical stimuli during the absolute refractory period, which enhances the strength of cardiac contractions. Increasing evidence exists suggesting that CCM improves symptoms in heart failure if various selection criteria are fulfilled. It is unknown how many people might benefit from this therapy. The aim […]

2 mins
A Simpson (Presenting Author) - Manchester Royal Infirmary, Manchester; S Allen - Manchester Royal Infirmary, Manchester; S Rooker - Manchester Royal Infirmary, Manchester; C Cunnington - Manchester Royal Infirmary, Manchester; F Ahmed - Manchester Royal Infirmary, Manchester; A Zaidi - Manchester Royal Infirmary, Manchester

Introduction: Implantable cardioverter-defibrillators (ICDs) are conventionally programmed to deliver maximum energy shocks for the treatment of ventricular arrhythmias. DeFT Response™ is an algorithm available in Abbott ICDs that reduces the typical shock duration from 10.0 ms to 7.5-8.0 ms. This technology has been shown to reduce the risk of pro-arrhythmia, and has been successfully used […]

2 mins
WI Umeojiako (Presenting Author) - Darent Valley Hospital, Dartford; M Dali - Darent Valley Hospital, Dartford; M Lewis - Darent Valley Hospital, Dartford; T Chan - Darent Valley Hospital, Dartford; T Patten - Darent Valley Hospital, Dartford; J Glessinger - Darent Valley Hospital, Dartford; T Webb - Darent Valley Hospital, Dartford; P Kabunga - Darent Valley Hospital, Dartford

Background: Electrical cardioversion (ECV) is frequently performed for persistent atrial fibrillation (AF). Although several large trials have suggested that rate control in AF may be non-inferior to rhythm-based strategies, individual patients may have better outcomes in terms of quality of life if sinus rhythm (SR) is achieved and maintained. This real-world, prospective observational study aimed […]

< 1 min
CL Coyle (Presenting Author) - Imperial College, London; I Mann - Imperial College, London; J Chow - Imperial College, London; N Qureshi - Imperial College, London; M Koa-Wing - Hammersmith Hospital, London; Z Whinnett - Imperial College, London; PB Lim - Imperial College, London; DP Francis - Imperial College, London; N Peters - Imperial College, London; N Linton - Imperial College, London; P Kanagaratnam - Imperial College, London

Background: Applying conventional approaches of ‘window of interest’ setting and local activation time (LAT) assignment to map atrial fibrillation (AF) is difficult. We overcame this problem using an algorithm to time-shift for best match of adjacent electrograms, using these relative differences in timing to create wavefront activation maps. Understanding AF also requires the interpretation of […]

2 mins
C O’Neill (Presenting Author) - Royal Brompton and Harefield NHS Foundation Trust, London; S Griffiths - Royal Brompton and Harefield NHS Foundation Trust, London; K Lascelles - Royal Brompton and Harefield NHS Foundation Trust, London; J Jarman - Royal Brompton and Harefield NHS Foundation Trust, London

Introduction: In February 2020 the British Heart Rhythm Society (BHRS) published updated standards for the follow up of cardiac rhythm devices which included new standards for report writing following device interrogations. Creation and adherence to these guidelines can provide structured device reports to facilitate the safe delivery of high-quality patient care. These guidelines were used […]

Introduction: Long QT Syndrome type 1 (LQT1) is caused by mutations in KCNQ1. KCNQ1 co-assembles with KCNE1 to underlie the slow delayed rectifier potassium current (IKs). The relative contribution of IKs to ventricular repolarisation is thought to be greater during sympathetic activation. Beta-adrenergic receptor stimulation leads to activation of Protein Kinase A (PKA) and subsequent phosphorylation of […]

2 mins
S Dutta (Presenting Author) - Northampton General Hospital, Northampton; H Sall - Nottingham University Hospital, Nottingham; YC Chan - Northampton General Hospital, Northampton; AS Mahmood - Northampton General Hospital, Northampton; M Pederson - Northampton General Hospital, Northampton; J Timperley - Northampton General Hospital, Northampton; D Sharman - Northampton General Hospital, Northampton

Introduction: The Micra TPS, a leadless single-chamber ventricular pacemaker, is increasingly preferred over the transvenous system. Its significantly smaller profile and fewer reported adverse effects, without compromising the pacing efficacy, makes it an innovative pacing device. We report the first sequential 75 Micra insertion cases in Northampton General Hospital (NGH) and 6 months post insertion […]

2 mins
S Ross (Presenting Author) - Nottingham University Hospitals NHS Trust, Nottingham; S Jamil-Copley - Nottingham University Hospitals NHS Trust, Nottingham; AJ Ahsan - Nottingham University Hospitals NHS Trust, Nottingham; AD Staniforth - Nottingham University Hospitals NHS Trust, Nottingham, T Robinson - Nottingham University Hospitals NHS Trust, Nottingham

Background: Cardiac centres are facing increasing demand for elective AF ablation, which has conventionally required overnight admission due to potential procedural complications. Routine care has included trans-thoracic echocardiography (TTE) one day after ablation to exclude procedure-related pericardial effusion prior to discharge. Local audit suggested this did not detect significant new effusion compared to on table […]

2 mins
AN Bhuva (Presenting Author) - Barts Heart Centre, London; A Graham - Barts Heart Centre, London; V Kanthasamy - Barts Heart Centre, London; J Gonzalez-Panizo - Barts Heart Centre, London; N Srinivasan - Barts Heart Centre, London; A Muthumala - Barts Heart Centre, London; P Moore - Barts Heart Centre, London; M Dhinoja - Barts Heart Centre, London

Introduction: There is limited experience of ultrasound (US) guided axillary vein access for cardiac electronic device implantation in the United Kingdom. We investigated the safety, efficacy, learning curve, and radiation exposure of US-guided axillary vein access. Methods: US-guided axillary vein access was attempted in consecutive patients requiring cardiac device implantation between June 2018 and November […]

2 mins
C Monkhouse (Presenting Author) - Barts Heart Centre, London; A Chow - Barts Heart Centre, London; R Hunter - Barts Heart Centre, London; P Lambiase - Barts Heart Centre, London; M Earley - Barts Heart Centre, London; RJ Schilling - Barts Heart Centre, London; N Srinivasan - Barts Heart Centre, London

Background: Covid-19 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has resulted in a significant number of increased hospitalizations and excess deaths worldwide. Though reports regarding myocardial injury/inflammation relating to Covid-19 are known, little is known about larger scale effects of the virus on cardiac arrhythmias. Additionally, it is […]

2 mins
HK Cheng (Presenting Author) - University of Hong Kong, Pok Fu Lam; RP Lee - Queen Elizabeth University Hospital, Glasgow; D Doherty - University of Glasgow, Glasgow; J Dawson - University of Glasgow, Glasgow; AH Abdul-Rahim - University of Glasgow, Glasgow; AC Cameron - University of Glasgow, Glasgow

Introduction: Extended cardiac monitoring increases atrial fibrillation (AF) detection after stroke but is unlikely to be available for all patients due to cost and may not be necessary for all patients. Identifying patients at higher or lower risk of AF detection after stroke may allow the duration of cardiac monitoring to be decided on a […]

< 1 min
GS Dhillon (Presenting Author) - Barts Heart Centre, London; N Ahluwalia - Barts Heart Centre, London; S Honarbakhsh - Barts Heart Centre, London; A Graham - Barts Heart Centre, London; A Creta - Barts Heart Centre, London; H Abbass - Barts Heart Centre, London; A Chow - Barts Heart Centre, London; MJ Earley - Barts Heart Centre, London; PD Lambiase - Barts Heart Centre, London; RJ Schilling - Barts Heart Centre, London; RJ Hunter - Barts Heart Centre, London

Background: We evaluated the effect of adenosine upon mechanisms sustaining persistent AF through analysis of contact electrograms and ECGI mapping. Methods: Persistent AF patients undergoing catheter ablation were included. ECGI maps and cycle length (CL) measurements were recorded in the left and right atrial appendages and repeated following adenosine administration. Potential drivers (PDs) were defined […]

2 mins
KF Makhdoom (Presenting Author) - Liverpool Heart and Chest, Liverpool; S Dalvi (Presenting Author) - Liverpool Heart and Chest Hospital NHS Trust, Liverpool; M Hall - Liverpool Heart and Chest Hospital, Liverpool; A Rao (Presenting Author) - Liverpool Heart and Chest, Liverpool

Background: Heart rhythm emergencies require specialist expertise from cardiologists and cardiologists who specialise in heart rhythm disorders. Currently access to such services across Liverpool and the wider UK is insufficient. This has led to a number of high-profile adverse events where in some cases have resulted in avoidable morbidity and mortality. In particular, patients presenting […]

2 mins
N Ahluwalia (Presenting Author) - St Bartholomew’s Hospital, London; R Zakeri - Royal Brompton Hospital, London; D Jones - Royal Brompton Hospital, London; W Hussain - Royal Brompton Hospital, London; J Jarman - Royal Brompton Hospital, London; V Markides - Royal Brompton Hospital, London; M Earley - St Bartholomew’s Hospital, London; S Sporton - St Bartholomew’s Hospital, London; RJ Schilling - St Bartholomew’s Hospital, London; RJ Hunter - St Bartholomew’s Hospital, London; T Wong - Royal Brompton Hospital, London

Introduction: In addition to symptomatic improvement, catheter ablation (CA) of atrial fibrillation (AF) improves left ventricular systolic function and functional capacity when performed in selected patients with heart failure. The impact of CA on long term outcome in the heart failure cohort is poorly understood. Furthermore, the impact of early ablation for all patients versus […]

2 mins
A Sufi (Presenting Author) - Imperial College London, London; J Brook - Imperial College London, London; D Agha-Jaffar - Imperial College London, London; D Pitcher - Imperial College London, London; BS Handa - Imperial College London, London; NA Qureshi - Imperial College London, London; J Perkins - Royal Veterinary College, University of London, Hertfordshire; A Jothidasan - Harefield Hospital, Harefield; FS Ng - Imperial College London, London; S Harding - Imperial College London, London; AA Bharath - Imperial College London, London; NS Peters - Imperial College London, London; CD Cantwell - Imperial College London, London; RA Chowdhury - Imperial College London, London

Background: Electrogram (EGM)-guided catheter ablation for atrial fibrillation (AF) has poor long-term outcomes and requires further research. Although clinical studies are considered the gold standard, they are restricted by low numbers of volunteers, safety of procedures, and ethical considerations. Small animal models lack clinical translatability due to their lack of similarity to human hearts. Analysis of […]

2 mins
J Shukla (Presenting Author) - Federated4Health, London; A Ahmed - Federated4Health, London; R Chowdhury - Federated4Health, London; A Lim - Federated4Health, London; A Sadiq - Federated4Health, London; C Osmund - Federated4Health, London; H Rawesh - Federated4Health, London; L Nwoye - Federated4Health, London; L Khatib - Federated4Health, London; M Battal - Federated4Health, London; S Naz - Federated4Health, London

Introduction: Clinical pharmacists are a new workforce in Primary Care Networks (PCN) and can play a critical role in realising the NHS Long Term Plan ambition, principally through secondary prevention.1 A centralised pharmacist model was implemented in the delivery of the NHSE Atrial Fibrillation (AF) patient optimisation demonstrator programme 2018-2020 aimed at preventing AF related stroke […]

2 mins
E Maclean (Presenting Author) - St Bartholomew’s Hospital, London; R Simon - St Bartholomew’s Hospital, London; R Ang - St Bartholomew’s Hospital, London; G Dhillon - St. Bartholomew’s Hospital, London; S Ahsan - St. Bartholomew’s Hospital, London; F Khan - St Bartholomew’s Hospital, London; M Earley - St Bartholomew’s Hospital, London; PD Lambiase - St Bartholomew’s Hospital, London; J Rosengarten - St Bartholomew’s Hospital, London; A Chow - St Bartholomew’s Hospital, London; M Dhinoja - St Bartholomew’s Hospital, London; R Providencia - St Bartholomew’s Hospital, London; V Markides - Royal Brompton Hospital, London; T Wong - Royal Brompton Hospital, London; RJ Hunter - St Bartholomew’s Hospital, London; JM Behar - Royal Brompton Hospital, London

Introduction: Anatomical studies demonstrate significant variation in cavotricuspid isthmus (CTI) architecture. We hypothesised that ablation index (AI) may further our understanding of energy delivery across the CTI. Methods: 38 patients underwent CTI ablation at two cardiothoracic hospitals. Operators delivered 682 lesions in total with a target AI of 600 Wgs. Ablation parameters were recorded every […]

2 mins
KZ Win (Presenting Author) - Hereford County Hospital, Hereford; J Sangha - Hereford County Hospital, Hereford; A Mayo-Evans - Hereford County Hospital, Hereford; M Gupta - Hereford County Hospital, Hereford; Z Dad - Hereford County Hospital, Hereford; AC Epstein - Hereford County Hospital, Hereford; JM Glancy - Hereford County Hospital, Hereford; N Prasad - Hereford County Hospital, Hereford

Introduction: Shockable ventricular arrhythmias account for one third of all cardiovascular deaths worldwide. Several randomised control trials have demonstrated ICD and CRT-D devices reduce mortality however the primary concern for both patient and physician remain inappropriate shocks. Aside from the pain and psychological impact, inappropriate shocks have also been independently associated with mortality in patient’s […]

2 mins
N Papageorgiou (Presenting Author) - Barts Heart Centre, London; A Tyrlis - Barts Heart Centre, London; A Chow - Barts Heart Centre, London; M Lowe - Barts Heart Centre, London; C Monkhouse - Barts Heart Centre, London; A Muthumala - Barts Heart Centre, London; A Creta - Barts Heart Centre, London; M Dhinoja - Barts Heart Centre, London; RJ Hunter - Barts Heart Centre, London; S Sporton - Barts Heart Centre, London; MJ Earley - Barts Heart Centre, London; RJ Schilling - Barts Heart Centre, London; M Finlay - Barts Heart Centre, London

Introduction: Emergency out-of-hours destination cardiovascular implantable device (CIDs) insertion has become established as preferable to temporary pacing waiting in anticipation of a working hours procedure slot. A frequent conundrum is the patient who may benefit from a more complex CID such as implantable cardioverter defibrillators (ICD) or cardiac resynchronization therapy (CRT), but who requires immediate […]

11
View All Issues

Comprising articles contributed by renowned thought leaders, European Journal of Arrhythmia & Electrophysiology is a peer reviewed, free-to-access, bi-annual journal that aims to disseminate best practice through review articles addressing the most important and salient developments in the arrhythmia and electrophysiology fields in practical terms.

European Journal of Arrhythmia & Electrophysiology
Frequency: Two print issues per year (Summer & Winter); ePub ahead of print throughout the year.
Print ISSN: 2058-3869 Electronic ISSN: 2058-3877

Close Popup